Viemed Healthcare, Inc. - Common Shares (VMD)
7.9100
0.00 (0.00%)
Viemed Healthcare Inc is a healthcare company that specializes in providing innovative home healthcare solutions, primarily focusing on the treatment and management of patients with chronic respiratory conditions
The company offers a range of services, including the rental and maintenance of medical equipment such as ventilators and oxygen therapy systems, as well as comprehensive patient care programs aimed at improving health outcomes. By leveraging technology and data analytics, Viemed aims to enhance the quality of care for patients while efficiently managing their healthcare needs within the comfort of their homes.
![](https://cdn.benzinga.com/files/images/story/2025/01/17/Palantir--Salesforce--Okta--Meta--And-Te.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 17, 2025
![](https://cdn.benzinga.com/files/images/story/2024/12/27/Amazon--Crowdstrike--Autodesk--Dell--And.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 27, 2024
![](https://cdn.benzinga.com/files/images/story/2024/12/16/Super-Micro-Computer-Inc-.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 16, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
VMD stock results show that Viemed Healthcare missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024
![](https://investorplace.com/wp-content/uploads/2021/09/undervalued-stocks.jpg)
While consumer prices may be hot, these stocks undervalued stocks to buy under $10 proves you can still catch a bargain.
Via InvestorPlace · August 16, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1437.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • HNI (NYSEHNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
Via Benzinga · May 8, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_135.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • argenx (NASDAQARGX) is expected to report quarterly loss at $3.03 per share on revenue of $176.89 million.
Via Benzinga · March 2, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • CTS (NYSECTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via Benzinga · March 6, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • GSK (NYSEGSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via Benzinga · November 1, 2023
![](https://cdn.benzinga.com/files/images/story/2023/03/03/image16.jpg?width=1200&height=800&fit=crop)
Gainers ObsEva SA (NASDAQOBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.
Via Benzinga · March 3, 2023
![](https://investorplace.com/wp-content/uploads/2019/08/healthcare1600c.jpg)
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio.
Via InvestorPlace · February 12, 2023
![](https://investorplace.com/wp-content/uploads/2022/10/consulting1600.png)
If you only have a few bucks to spare for investing, these are the best stocks to buy under $7 that bargain hunters should target.
Via InvestorPlace · November 12, 2022
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3499.jpeg?width=1200&height=800&fit=crop)
According to Benzinga Pro, during Q3, Viemed Healthcare (NASDAQVMD) earned $1.05 million, a 9.1% increase from the preceding quarter. Viemed Healthcare also posted a total of $35.76 million in sales, a 7.35% increase since Q2.
Via Benzinga · November 10, 2022
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_3498.jpeg?width=1200&height=800&fit=crop)
According to Benzinga Pro, during Q3, Viemed Healthcare (NASDAQVMD) earned $1.05 million, a 9.1% increase from the preceding quarter. Viemed Healthcare also posted a total of $35.76 million in sales, a 7.35% increase since Q2.
Via Benzinga · November 10, 2022
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5626.jpeg?width=1200&height=800&fit=crop)
Viemed Healthcare (NASDAQVMD) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that Viemed Healthcare will report an earnings per share (EPS) of $0.04.
Via Benzinga · October 31, 2022
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_5625.jpeg?width=1200&height=800&fit=crop)
Viemed Healthcare (NASDAQVMD) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that Viemed Healthcare will report an earnings per share (EPS) of $0.04.
Via Benzinga · October 31, 2022
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_9169.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • BP (NYSEBP) is estimated to report quarterly earnings at $2.07 per share on revenue of $64.76 billion.
Via Benzinga · November 1, 2022
![](https://cdn.benzinga.com/files/images/story/2022/08/04/image9.jpg?width=1200&height=800&fit=crop)
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQQNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.
Via Benzinga · August 4, 2022
![](https://cdn.benzinga.com/files/images/story/2022/08/03/image47.jpg?width=1200&height=800&fit=crop)
Gainers Helius Medical Technologies, Inc. (NASDAQHSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.
Via Benzinga · August 3, 2022